BRIEF-CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates

Reuters
28 Mar
BRIEF-CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates

March 28 (Reuters) - CG Oncology Inc CGON.O:

  • CG ONCOLOGY REPORTS 2024 YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

  • CG ONCOLOGY INC: QTRLY LOSS PER SHARE $0.46

Source text: ID:nGNXbvgS0k

Further company coverage: CGON.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10